Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
2:06p ET 2/23/2022 - Globe Newswire
PURA Confirms Asia Pacific Hemp Partnership Developments And 2022 Revenue Increase Potential
Mentioned: PURA
Puration, Inc. (OTC Pink: PURA) today confirmed the company is on the verge of striking its first partnership opportunity in the Asia Pacific Region. The partnership could result in PURA raising its $10 million stretch revenue target.
PURA included details on its initiative to expand its partnership income potential with a new global emphasis in the progress report update on its 2022 strategic plan published yesterday.
The entire update can be viewed at:
PURA Aims To Disrupt Textile And Lumber Industries With Sustainable Hemp Solutions
The update includes the latest information on PURA's initiatives with North American Cannabis Holdings, Inc. (OTC Pink: USMJ), Alkame Holdings, Inc. (OTC Pink: ALKM) and PAO Group, Inc. (OTC Pink: PAOG).
For more information on Puration, visit http://www.purationinc.com
Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.
For More Information Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
https://ml.globenewswire.com/media/66f6e1d0-5022-4c69-b2bc-7a68fae6a614/small/pura-logo-update-may-12-jpg.jpg
https://ml.globenewswire.com/media/66f6e1d0-5022-4c69-b2bc-7a68fae6a614/small/pura-logo-update-may-12-jpg.jpg
comtex tracking
COMTEX_402937827/2010/2022-02-23T14:06:54
Has this company even made 1 dime. Funny right before Christmas there were story after story about all of the products that were being released and we were going to make millions. Since after Christmas not 1 word. Looks like people need to be sent to prison for FRUD. I don't understand how these idiots can remain in business scaming more people every day.
11:34a ET 2/23/2022 - Globe Newswire
PURA Features USMJ EVERx CBD Sports Nutrition Beverage Relaunch - Tradeshow Announcement Tomorrow
Mentioned: PURA USMJ
Puration, Inc. (OTC Pink: PURA) today highlighted that its partnership with North American Cannabis Holdings, Inc. (OTC Pink: USMJ) where PURA receives a royalty on USMJ's sales generated from the distribution of the EVERx CBS Sports Nutrition Beverage, was featured in PURA's update, published yesterday, on the company's progress toward its 2022 strategic objectives. USMJ plans to make a major tradeshow announcement tomorrow where EVERx will be officially relaunched.
PURA's update published yesterday provided the company's latest progress around PURA's new initiative, launched just last year, to expand the utilization of hemp worldwide under the brand name Farmersville Hemp. PURA is building a co-op of hemp growers and processors to raise market awareness around the multitude of yet to be realized uses of hemp and build a brand name to benefit all co-op participants under the name Farmersville Hemp.
The update, in the form of a shareholder letter from the company CEO, Brian Shibley, is published again, in its entirety, below:
Dear Shareholders:
Trepidation is prevailing over the market at the moment, but it will not last. The global economy just has too much opportunity for growth. The world population is almost 8 billion and less than 2 billion of that population reside within developed economic regions. The ROI potential of the companies that will build the products for, and deliver the services to the underserved 6 billion gives far more reason for optimism than any existing cause for concern that is presently weighing on the market. The market will turn around.
PURA has tremendous opportunity to rapidly grow by participating in the ROI potential that comes from serving the 6 billion underserved.
While companies operating in the developed economies of the world face investing in the retooling of existing process to eliminate carbon emission so they can simply deliver the same products and services they already provide, companies in the developing economies of the world have the opportunity to build clean first to market solutions.
PURA knows the integration of hemp into new products and services can serve developing economies with carbon neutral solutions that leapfrog the overall caliber of carbon emitting like solutions currently serving developed economies.
Hemp is a textile and lumber industry disruptor. Hemp fiber is an alternative to cotton and traditional construction lumber that in fact has many characteristics superior to cotton and traditional lumber before considering the environmental benefits of using hemp. Hemp grows faster than cotton and hard wood forests, uses less water and absorbs more carbon. Hemp can be used in the production of bioplastics and has even been tested for use in supercapacitors which hold the potential to outperform batteries and do so with far less detriment to the environment.
PURA has introduced its Farmersville Hemp Brand strategy to usher industrial hemp solutions into the market. PURA has a practical three-pronged approach. Practical, because all three prongs generate revenue.
The first component of PURA's three-pronged approach is education. PURA is marketing a consultative hemp education program to existing businesses to show existing businesses how hemp can be integrated into their existing product and service offerings to deliver a more efficient and sustainable solution.
The second component of PURA's three-pronged approach is branding. PURA is building a brand around the Farmersville Hemp name and also building a co-op of hemp growers and processors that can altogether market under the Farmersville Hemp Brand name.
Last week, the U.S. Department of Agriculture (USDA) published the first ever survey on the newly legal hemp industry. The report drew on over 20,000 surveyed growers. That's 20,000 potential Farmersville Hemp co-op participants.
The third component of PURA's three-pronged approach is partnership. PURA is making investments in hemp related enterprises that contribute to the Farmersville Hemp Brand and also generate a return-on-investment opportunity.
PURA owns a five percent stake in Alkame Holdings, Inc. (OTC Pink: ALKM), a proven cannabis consumable co-packer. PURA owns a royalty interest in the EVERx CBD Sports Nutrition Beverage, a product of North American Cannabis Holdings, Inc. (OTC Pink: USMJ). PURA has notably made a $1 million strategic investment through a limited partnership in Hydrobuilder Holdings, a company providing cannabis growing supplies and planning to IPO later this year.
PURA anticipates generating at least $1 million in revenue in 2022 with the potential to reach $10 million in revenue. The $1 million target is based on PURA's education services, and the $10 million target is based on PURA's branding and partnership strategies.
Our branding and partnership initiatives are establishing significant traction and our corresponding overall opportunity to realize increased revenue is likewise improving.
USMJ is relaunching EVERx with a major trade show announcement coming soon.
ALKM is gaining traction with regular announcements of new co-packing patterns.
Hydrobuilder Holdings continues to rollup related industry companies and firm up IPO plans.
All three have the potential to generate substantial returns for PURA this year and beyond.
PURA continues to expand its partnership income potential with a new global emphasis. The hemp industry is dominated today by the Asia Pacific Region. PURA is on the verge of striking its first partnership opportunity in the Asia Pacific Region. The partnership could result in PURA raising its $10 million stretch revenue target.
The letter here today is a progress report update on our 2022 strategic plan published earlier this year. Look for more updates to come.
In closing I will add that I do not believe that our current share price is a reflection of PURA's value. I feel the share price is impacted by the prevailing trepidation in the overall market and by the underestimation of hemp's overall disruptive potential. I am confident the market will overcome its current trepidation and again see the overwhelming global economic growth potential. I am also confident the disruptive potential of hemp will become more and more visible. In turn, I am optimistic that market condition improvements and the improved visibility of hemp's potential will have a positive impact on PURA's share price.
Sincerely,
Brian Shibley
CEO PURA
For more information on Puration, visit http://www.purationinc.com
Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.
For More Information Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
https://ml.globenewswire.com/media/66f6e1d0-5022-4c69-b2bc-7a68fae6a614/small/pura-logo-update-may-12-jpg.jpg
https://ml.globenewswire.com/media/66f6e1d0-5022-4c69-b2bc-7a68fae6a614/small/pura-logo-update-may-12-jpg.jpg
comtex tracking
9:00a ET 2/22/2022 - Globe Newswire
PURA Aims To Disrupt Textile And Lumber Industries With Sustainable Hemp Solutions
Puration, Inc. (OTC Pink: PURA) today published an update on the company's progress toward its 2022 strategic objectives.
PURA has launched an initiative to expand the utilization of hemp worldwide under the brand name Farmersville Hemp. PURA is building a co-op of hemp growers and processors to raise market awareness around the multitude of yet to be realized uses of hemp and build a brand name to benefit all co-op participants under the name Farmersville Hemp.
The update today comes in the form of a shareholder letter from the company CEO, Brian Shibley. The letter is included in its entirety below:
Dear Shareholders:
Trepidation is prevailing over the market at the moment, but it will not last. The global economy just has too much opportunity for growth. The world population is almost 8 billion and less than 2 billion of that population reside within developed economic regions. The ROI potential of the companies that will build the products for and deliver the services to the underserved 6 billion gives far more reason for optimism than any existing cause for concern that is presently weighing on the market. The market will turn around.
PURA has tremendous opportunity to rapidly grow by participating in the ROI potential that comes from serving the 6 billion underserved.
While companies operating in the developed economies of the world face investing in the retooling of existing process to eliminate carbon emission so they can simply deliver the same products and services they already provide, companies in the developing economies of the world have the opportunity to build clean first to market solutions.
PURA knows the integration of hemp into new products and services can serve developing economies with carbon neutral solutions that leapfrog the overall caliber of carbon emitting like solutions currently serving developed economies.
Hemp is a textile and lumber industry disruptor. Hemp fiber is an alternative to cotton and traditional construction lumber that in fact has many characteristics superior to cotton and traditional lumber before considering the environmental benefits of using hemp. Hemp grows faster than cotton and hard wood forests, uses less water and absorbs more carbon. Hemp can be used in the production of bioplastics and has even been tested for use in supercapacitors which hold the potential to outperform batteries and do so with far less detriment to the environment.
PURA has introduced its Farmersville Hemp Brand strategy to usher industrial hemp solutions into the market. PURA has a practical three-pronged approach. Practical, because all three prongs generate revenue.
The first component of PURA's three-pronged approach is education. PURA is marketing a consultative hemp education program to existing businesses to show existing businesses how hemp can be integrated into their existing product and service offerings to deliver a more efficient and sustainable solution.
The second component of PURA's three-pronged approach is branding. PURA is building a brand around the Farmersville Hemp name and also building a co-op of hemp growers and processors that can altogether market under the Farmersville Hemp Brand name.
Last week, the U.S. Department of Agriculture (USDA) published the first ever survey on the newly legal hemp industry. The report drew on over 20,000 surveyed growers. That's 20,000 potential Farmersville Hemp co-op participants.
The third component of PURA's three-pronged approach is partnership. PURA is making investments in hemp related enterprises that contribute to the Farmersville Hemp Brand and also generate a return-on-investment opportunity.
PURA owns a five percent stake in Alkame Holdings, Inc. (OTC Pink: ALKM), a proven cannabis consumable co-packer. PURA owns a royalty interest in the EVERx CBD Sports Nutrition Beverage, a product of North American Cannabis Holdings, Inc. (OTC Pink: USMJ). PURA has notably made a $1 million strategic investment through a limited partnership in Hydrobuilder Holdings, a company providing cannabis growing supplies and planning to IPO later this year.
PURA anticipates generating at least $1 million in revenue in 2022 with the potential to reach $10 million in revenue. The $1 million target is based on PURA's education services, and the $10 million target is based on PURA's branding and partnership strategies.
Our branding and partnership initiatives are establishing significant traction and our corresponding overall opportunity to realize increased revenue is likewise improving.
USMJ is relaunching EVERx with a major trade show announcement coming soon.
ALKM is gaining traction with regular announcements of new co-packing patterns.
Hydrobuilder Holdings continues to rollup related industry companies and firm up IPO plans.
All three have the potential to generate substantial returns for PURA this year and beyond.
PURA continues to expand its partnership income potential with a new global emphasis. The hemp industry is dominated today by the Asia Pacific Region. PURA is on the verge of striking its first partnership opportunity in the Asia Pacific Region. The partnership could result in PURA raising its $10 million stretch revenue target.
The letter here today is a progress report update on our 2022 strategic plan published earlier this year. Look for more updates to come.
In closing I will add that I do not believe that our current share price is a reflection of PURA's value. I feel the share price is impacted by the prevailing trepidation in the overall market and by the underestimation of hemp's overall disruptive potential. I am confident the market will overcome its current trepidation and again see the overwhelming global economic growth potential. I am also confident the disruptive potential of hemp will become more and more visible. In turn, I am optimistic that market condition improvements and the improved visibility of hemp's potential will have a positive impact on PURA's share price.
Sincerely,
Brian Shibley
CEO PURA
For more information on Puration, visit http://www.purationinc.com
Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.
For More Information Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
https://ml.globenewswire.com/media/66f6e1d0-5022-4c69-b2bc-7a68fae6a614/small/pura-logo-update-may-12-jpg.jpg
https://ml.globenewswire.com/media/66f6e1d0-5022-4c69-b2bc-7a68fae6a614/small/pura-logo-update-may-12-jpg.jpg
comtex tracking
COMTEX_402861744/2010/2022-02-22T09:00:06
This PR is really good because it's...
not the same ol' PAOG bs; this time PURA bs! (btw, there's a pun there)
Remember, the $18 billion target is something PURA dreamed up. Personally, if I was a PURA bag holder, I much rather mgt work on getting me my fn divy from PAOG than wasting time "targeting global markets" and concocting pie in the sky estimates of the size of those markets.
PURA & PAOG a marriage made in the boiler rooms of the OTC.
I have seen this for over 6 months now
So what. What have they done? Really getting sick of them posting news story about how much the market is worth. How about showing me how much money that we are making? Don't care about the how much the market is worth. How much of it are we getting.
Also with all of the new products that supposedly released at the end of the year last year. HOW ABOUT AN UPDATE ON HOW MUCH WAS MADE. very sorry I ever invested in this pos. I will never understand how these fraudulent operations can remain in business. If I went around screwing people out of their money I would end up in jail
I have seen this for over 6 months now
So what. What have they done? Really getting sick of them posting news story about how much the market is worth. How about showing me how much money that we are making? Don't care about the how much the market is worth. How much of it are we getting.
Also with all of the new products that supposedly released at the end of the year last year. HOW ABOUT AN UPDATE ON HOW MUCH WAS MADE. very sorry I ever invested in this pos. I will never understand how these fraudulent operations can remain in business. If I went around screwing people out of their money I would end up in jail
1:05p ET 2/16/2022 - PR Newswire
PURA Targets $18 Billion Global Market With Farmersville Hemp Brand
Puration, Inc. (USOTC: PURA) today emphasized that the company's new Farmersville Hemp brand is a global brand. PURA management pointed out that the U.S. today is only a small fraction of the global hemp market currently dominated by the Asia Pacific region.
Last year, PURA launched an initiative to expand the utilization of hemp worldwide under the brand name Farmersville Hemp.
PURA is building a co-op of hemp growers and processors to raise market awareness around the multitude of yet to be realized uses of hemp and build a brand name to benefit all co-op participants under the name Farmersville Hemp.
Today, PURA management points out that its co-op participants reach substantially includes global targets.
The industrial hemp industry, to include the portion of CBD exclusively from hemp, is anticipated to grow to $18 billion by 2026.
PURA management thinks this is a substantial underestimate because the industry has yet to recognize the multitude of ways hemp can be utilized.
The Sustainability Market is expected to expand from $9 billion reported in 2021 to over $41 billion by 2028.
PURA management believes the impact hemp can have on sustainability is not fully baked into the industrial hemp forecasts.
PURA anticipates generating $1 million in revenue in 2022 with the potential to reach $10 million in revenue this year. The $10 million revenue opportunity outlook is improving based on the recent progress of PURA's co-op partners.
PURA published a 2022 strategic overview at the onset of this year detailing the company's plan to grow revenue and increase shareholder value by driving market wide demand for the "multitude of yet to be realized uses of hemp."
Next week, On Tuesday, February 22nd, PURA management will publish its first progress update report on the execution of its strategic plan specifically focusing on the progress of the co-op partners that is improving PURA's 2022 revenue outlook.
PURA co-op partners include Alkame Holdings, Inc. (USOTC: ALKM), PAO Group, Inc. (USOTC: PAOG), North American Cannabis Holdings, Inc. (USOTC: USMJ), and UC Asset LP (OTCQX: UCASU).
For more information on Puration, visit http://www.purationinc.com
Disclaimer:This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.
For More Information Contact:Puration, Inc.Brian Shibley,info@aciconglomerated.com(800) 861-1350
https://c212.net/c/img/favicon.png?sn=LN64736&sd=2022-02-16
View original content:https://www.prnewswire.com/news-releases/pura-targets-18-billion-global-market-with-farmersville-hemp-brand-301483956.html
SOURCE Puration, Inc.
https://rt.prnewswire.com/rt.gif?NewsItemId=LN64736&Transmission_Id=202202161305PR_NEWS_USPR_____LN64736&DateId=20220216
comtex tracking
COMTEX_402522370/1005/2022-02-16T13:05:52
I agree putting out the same news without any proof of progress is a waste of time. We need revenue’s, products, inventory and profits forecast!
A congressmen from Maine introduced...
a bill that was referred to the agricultural committee. I can hardly control my excitement. I wonder how long it will take for ALKM, PAOG, USMJ, and UCASU to release the same PR over and over and over again saying nothing about something they have no input in or control over, but it sounds good. Shame they didn't have anything to say about the divy. JMHO
10:09a ET 2/14/2022 - Globe Newswire
PURA Industrial Hemp Business Positioned To Benefit From Hemp Advancement Act of 2022
Mentioned: PURA
Puration, Inc. (OTC Pink: PURA) retooled its experience with hemp last year to take on a much larger opportunity in 2022. PURA has launched an initiative to expand the utilization of hemp worldwide under the brand name Farmersville Hemp. PURA is building a co-op of hemp growers and processors to raise market awareness around the multitude of yet to be realized uses of hemp and build a brand name to benefit all co-op participants under the name Farmersville Hemp.
PURA management believes the Hemp Advancement Act of 2022, introduced last week, could substantially contribute to PURA's Farmersville Hemp Strategy.
The Act is intended to advance the industrial hemp momentum initiated under the 2018 Farm Bill.
PURA management is also eager to see the upcoming USDA National Hemp Report anticipated later this week on February 17. PURA expects the report to have important information to be utilized in the ongoing development of PURA's Farmersville Hemp strategy.
PURA recently published a 2022 strategic overview detailing the company's plan to grow revenue and increase shareholder value by driving market wide demand for the "multitude of yet to be realized uses of hemp."
PURA anticipates generating $1 million in revenue in 2022 with the potential to reach $10 million in revenue this year. The $10 million revenue opportunity is enhanced by the progress of PURA's co-op partners.
PURA co-op partners include Alkame Holdings, Inc. (OTC Pink: ALKM), PAO Group, Inc. (OTC Pink: PAOG), North American Cannabis Holdings, Inc. (OTC Pink: USMJ), and UC Asset LP (OTCQX: UCASU).
For more information on Puration, visit http://www.purationinc.com
Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.
For More Information Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
https://ml.globenewswire.com/media/66f6e1d0-5022-4c69-b2bc-7a68fae6a614/small/pura-logo-update-may-12-jpg.jpg
https://ml.globenewswire.com/media/66f6e1d0-5022-4c69-b2bc-7a68fae6a614/small/pura-logo-update-may-12-jpg.jpg
comtex tracking
COMTEX_402382340/2010/2022-02-14T10:09:47
Do you have any interest in this company
$PAOG PAOG Expects Increased Visibility For Its CBD Nutraceuticals From USMJ Ecommerce Campaign
Press Release | 02/03/2022
Sandusky, OH, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company expects to enjoy increased market visibility for its RX Branded CBD Nutraceuticals resulting from the kickoff of the USMJ Ecommerce expansion campaign announced earlier today.
PAOG currently markets its own independent line of CBD nutraceutical products under its “RX” label available for sale on North American Cannabis Inc.’s (OTC Pink: USMJ) ecommerce site www.usmj.com.
PAOG is also working with Puration, Inc. (OTC Pink: PURA) on the development of additional CBD nutraceuticals products under PURA’s Farmersville Hemp brand.
PAOG owns intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960).
PAOG is developing both pharmaceutical and nutraceutical treatments for humans based on this intellectual property.
PAOG’s CBD formulation, derived from a patented cannabis extraction process, is years in the making for the treatment of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. PAOG is developing the CBD formulation with the intent of delivering an approved pharmaceutical treatment under the brand name RespRx.
For more information on Puration, visit http://www.purationinc.com
Learn more about PAOG at www.paogroupinc.com.
Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.
For More Information Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Jim DiPrima
888-272-6472
info@pao.group
LMAO - ROFLMFAO - OMG.... Thank you for that link.... That's got to be the most ridiculous products at the most outrageous over priced points I've ever seen.... and I have seen many many many sites selling CBD's.
The funniest thing is the "Relax RX CBD Salve" - lol - it's labeled REHABRX CBD Salve... They couldn't even bother to cover the label of the product they bought to resell.... Products look like labels were made by a third grader... What a joke.... sheesh
But you can pay with bitcoins, or even dogecoins.... lol
https://usmj.com/collections/paog/products/relax-rx-full-spectrum-cbd-muscle-salve-900mg
Oh, they have products alright. USMJ has....
morphed into an online CBD shop and there are three PAOG CBD products among those they are hawking. Of course, everyone and their f'n dog offers the same type of CBD products in the same dosages. So differentiating themselves in the marketplace should be a challenge.
PAOG is trying to do this by hawking their super secret patented extraction process, but I don't think that's gonna do it. Just look at the reaction these blockbuster products have generated in both in the market and among PAOG shareholders. They've had these for sale on the USMJ site for awhile now and not one of the products has generated a review of any kind.
BTW here's the link you are looking for....
https://usmj.com/collections/paog
Try not to laugh too hard.
Incredible - this PR looks like it was written by a 3 year old... wait, more like a 2 year old.... sheesh...
And funny how they don't even mention the PAO SCAM.... lmao...
But they are ready at the starting line... You just can't make this stuff up....
https://finance.yahoo.com/news/usmj-prepares-kickoff-cannabis-ecommerce-143800136.html
USMJ Prepares To Kickoff Cannabis Ecommerce Expansion Campaign
North American Cannabis Holdings, Inc.
Thu, February 3, 2022, 9:38 AM·1 min read
Dallas, TX, Feb. 03, 2022 (GLOBE NEWSWIRE) -- North American Cannabis Holdings, Inc. (OTC Pink: USMJ) today announced the company is ready at the starting line to kickoff a major expansion of its cannabis ecommerce business.
In September of last year, ACI Conglomerated, the controlling shareholder of USMJ and the controlling shareholder of Puration, Inc. (OTC Pink: PURA) and Priority Aviation, Inc. (OTC Pink: PJET), announced its plans to refocus and diversify its overall strategy with the three companies.
PJET diversified outside the cannabis industry entering the student life market.
PURA refocused its business on industrial hemp.
((by Drugdoctor>> WTF does this nonsense bolded below mean>>>??? LMAO))
USMJ, after exiting the cannabis retail restaurant market, is not focused on expanding its cannabis ecommerce footprint. February will be the kickoff of its expansion campaign.
Visit the company’s ecommerce site now and bookmark the site to watch for coming announcements and updates:
www.USMJ.com
Contact:
USMJ
Steven Rash
info@aciconglomerated.com
+1 (800) 861-1350
LOL - USMJ is not $PAOG and it's a scam too.... tooooooo funnnnnyyyy - next
Can you search USMJ E-COMMERCE there is all they’re products and pricing you can order some to be certain that they are real
Did you provide a link? LMAO
Why you saying no products did you check the site why you saying that there is no product that’s not true
LMAO - yep... that's what I thought... no products... nothing but a share dumping scam here... CEO is a scammer!
A little pricey but they have product
RX Branded CBD Nutraceuticals available USMJ Ecomerce look it up
Give me a link to any products they are selling... lol
Oh, it's a scam... that's very little disputed...
Have you tried any of there produts
Why you think this is a scam
It's time for a SEC shutdown of this scam.
None of these stocks are going to move unless we get positive earnings and proof of growth!
Still we can see trips from here...
PURA still hasn't gotten their divy and we've heard all this bs all before.
I can tell you what they have done they went from.01 to.002 in one year
Where are all of these billions of dollars that we were supposed to have made at the end of last year from all of the new products that went to market. I don't care about what they are going to do. I WANT TO KNOW WHAT HAVE THEY DONE?
9:37a ET 2/1/2022 - Globe Newswire
PURA Announces Solar Powered Enhancement For Farmersville Hemp Complex
Mentioned: PURA
Puration, Inc. (OTC Pink: PURA) today announced the company's Farmersville Hemp complex will be solar powered in conjunction with PURA's overall plans to market the environmental sustainability benefits of hemp-based solutions.
PURA recently published a 2022 strategic overview detailing the company's plan to grow revenue and increase shareholder value by driving market wide demand for the "multitude of yet to be realized uses of hemp."
PURA anticipates generating $1 million in revenue in 2022 with the potential to reach $10 million in revenue this year. The $10 million revenue opportunity is enhanced by the progress of PURA's co-op partners.
PURA is building a marketing co-op under the brand name "Farmersville Hemp."
PURA co-op partners include Alkame Holdings, Inc. (OTC Pink: ALKM), PAO Group, Inc. (OTC Pink: PAOG), North American Cannabis Holdings, Inc. (OTC Pink: USMJ), and UC Asset LP (OTCQX: UCASU).
Look for more details later this week on PURA's solar powered solution.
For more information on Puration, visit http://www.purationinc.com
Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.
For More Information Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
https://ml.globenewswire.com/media/66f6e1d0-5022-4c69-b2bc-7a68fae6a614/small/pura-logo-update-may-12-jpg.jpg
https://ml.globenewswire.com/media/66f6e1d0-5022-4c69-b2bc-7a68fae6a614/small/pura-logo-update-may-12-jpg.jpg
comtex tracking
COMTEX_401561559/2010/2022-02-01T09:37:28
9:42a ET 2/1/2022 - Globe Newswire
PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development
Mentioned: PAOG
PAO Group, Inc. (OTC Pink: PAOG) today republished its 2022 strategic update on the company's CBD pharmaceutical and nutraceutical development strategy. The update was originally released on Friday, January 27, 2022. The update is included in its entirety below:
PAO Group, Inc. is an emerging cannabis and CBD company targeting growth via two tracks - pharmaceutical and nutraceutical. The Company is developing a cannabis extract-based therapy to treat various respiratory diseases and illnesses including COPD. Recent independent research has confirmed PAOG's previous conclusions that CBD may also be a viable treatment for COVID-19.
PAOG has positioned itself as an emerging CBD Biopharma company on a development path to treat various and major respiratory diseases that represent billions in potential market sizes.
The Company has engaged a CRO to initiate the process for potential FDA approval of RespRx, its new flagship COPD treatment. COPD represents an estimated $14.1B market by 2025.
The World Health Organization estimates 65 million people worldwide are afflicted with moderate to severe COPD and GlobalData forecasts that the COPD treatment market will reach $14.1 billion by 2025. POAG, preclinical studies on COPD patients were conducted to evaluate the impact of its pharmaceutical grade cannabis extracts in combination with other therapies. Favorable results have triggered the planned PAOG development of this CBD-derived Biopharma product. PAOG has enter into an agreement with a Contract Research Organization (CRO) as a first step toward initiating an Investigational New Drug Application (IND) to commence the process for obtaining FDA approval for its RespRx as a COPD treatment.
PAOG acquired the proprietary formulations derived from a patented cannabis extraction process - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT."
With the patented intellectual property (IP) to include the existing and ongoing research and development, and favorable preclinical studies, management's over-lapping tracks is the development of a CBD Biopharma treatment for multiple respiratory-related diseases, notably COPD, COVID-19, and others.
In preclinical studies, experiments to evaluate the potential of cannabis extracts derived from the patented extraction process in the treatment of respiratory diseases were conducted. The experiments were designed to evaluate pure cannabis extracts and cannabis extracts in combination with other therapies in the treatment of chronic obstructive pulmonary disease (COPD) and Asthma. There are a significant number of genes associated with COPD and Asthma. The experiments evaluated the ability of various formulations to change Asthma or COPD associated gene expressions in human small airway epithelial cells. A cannabis extract alone demonstrated remarkable activity in gene arrays by up- or down-regulating individual genes by as much as 200-fold. Genes appearing especially sensitive to the introduction of cannabis extract were associated with inflammation, healing and cancer inhibition. Results from this series of experiments provided a baseline for comparison with data from subsequent studies, including a physiological study.
While the data behind PAOG's pharmaceutical research is strong and management is confident in the potential of the proprietary technology to result in an FDA approved treatment, management recognizes the path to revenue is long and not without substantial expense.
According, PAOG has initiated a nutraceutical development strategy building on the same proprietary technology driving its pharmaceutical developments. The nutraceutical development strategy is anticipated to drive rapid revenue growth and offset the pharmaceutical development expenses.
PAOG has already launched its own independent line of CBD nutraceutical products under its "RX" label available for sale on North American Cannabis Inc.'s (OTC Pink: USMJ) ecommerce site www.usmj.com. PAOG expects to soon be adding to the "RX" CBD nutraceutical product line.
PAOG has also recently announced the development of a new line of CBD nutraceutical products for Puration, Inc. (OTC Pink: PURA) now underway. PAOG also expects to make a strategic announcement with PURA regarding a new partnership on CBD nutraceutical production resources.
With the strategic overview provided today, PAOG management plans to follow up with a number of updates providing more detail on specific aspects of the strategic plan overviewed here today leading first with the anticipated joint announcement with PURA on the new nutraceutical production resource.
Learn more about PAOG at www.paogroupinc.com.
Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.
For More Information Contact:
Jim DiPrima
888-272-6472
info@pao.group
https://ml.globenewswire.com/media/508f5e75-8a3d-4880-b2f9-a76e7871234e/small/paog-new-logo-jpg.jpg
https://ml.globenewswire.com/media/508f5e75-8a3d-4880-b2f9-a76e7871234e/small/paog-new-logo-jpg.jpg
comtex tracking
COMTEX_401561790/2010/2022-02-01T09:42:01
4:57p ET 1/28/2022 - Globe Newswire
PAOG Publishes 2022 Strategic Update
Mentioned: PAOG
PAO Group, Inc. (OTC Pink: PAOG) today released a 2022 strategic update on the company's CBD pharmaceutical and nutraceutical development strategy. The update is included in its entirety below:
PAO Group, Inc. is an emerging cannabis and CBD company targeting growth via two tracks - pharmaceutical and nutraceutical. The Company is developing a cannabis extract-based therapy to treat various respiratory diseases and illnesses including COPD. Recent independent research has confirmed PAOG's previous conclusions that CBD may also be a viable treatment for COVID-19.
PAOG has positioned itself as an emerging CBD Biopharma company on a development path to treat various and major respiratory diseases that represent billions in potential market sizes.
The Company has engaged a CRO to initiate the process for potential FDA approval of RespRx, its new flagship COPD treatment. COPD represents an estimated $14.1B market by 2025.
The World Health Organization estimates 65 million people worldwide are afflicted with moderate to severe COPD and GlobalData forecasts that the COPD treatment market will reach $14.1 billion by 2025. POAG, preclinical studies on COPD patients were conducted to evaluate the impact of its pharmaceutical grade cannabis extracts in combination with other therapies. Favorable results have triggered the planned PAOG development of this CBD-derived Biopharma product. PAOG has enter into an agreement with a Contract Research Organization (CRO) as a first step toward initiating an Investigational New Drug Application (IND) to commence the process for obtaining FDA approval for its RespRx as a COPD treatment.
PAOG acquired the proprietary formulations derived from a patented cannabis extraction process - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT."
With the patented intellectual property (IP) to include the existing and ongoing research and development, and favorable preclinical studies, management's over-lapping tracks is the development of a CBD Biopharma treatment for multiple respiratory-related diseases, notably COPD, COVID-19, and others.
In preclinical studies, experiments to evaluate the potential of cannabis extracts derived from the patented extraction process in the treatment of respiratory diseases were conducted. The experiments were designed to evaluate pure cannabis extracts and cannabis extracts in combination with other therapies in the treatment of chronic obstructive pulmonary disease (COPD) and Asthma. There are a significant number of genes associated with COPD and Asthma. The experiments evaluated the ability of various formulations to change Asthma or COPD associated gene expressions in human small airway epithelial cells. A cannabis extract alone demonstrated remarkable activity in gene arrays by up- or down-regulating individual genes by as much as 200-fold. Genes appearing especially sensitive to the introduction of cannabis extract were associated with inflammation, healing and cancer inhibition. Results from this series of experiments provided a baseline for comparison with data from subsequent studies, including a physiological study.
While the data behind PAOG's pharmaceutical research is strong and management is confident in the potential of the proprietary technology to result in an FDA approved treatment, management recognizes the path to revenue is long and not without substantial expense.
According, PAOG has initiated a nutraceutical development strategy building on the same proprietary technology driving its pharmaceutical developments. The nutraceutical development strategy is anticipated to drive rapid revenue growth and offset the pharmaceutical development expenses.
PAOG has already launched its own independent line of CBD nutraceutical products under its "RX" label available for sale on North American Cannabis Inc.'s (OTC Pink: USMJ) ecommerce site www.usmj.com. PAOG expects to soon be adding to the "RX" CBD nutraceutical product line.
PAOG has also recently announced the development of a new line of CBD nutraceutical products for Puration, Inc. (OTC Pink: PURA) now underway. PAOG also expects to make a strategic announcement with PURA regarding a new partnership on CBD nutraceutical production resources.
With the strategic overview provided today, PAOG management plans to follow up with a number of updates providing more detail on specific aspects of the strategic plan overviewed here today leading first with the anticipated joint announcement with PURA on the new nutraceutical production resource.
Learn more about PAOG at www.paogroupinc.com.
Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.
For More Information Contact:
Jim DiPrima
888-272-6472
info@pao.group
https://ml.globenewswire.com/media/508f5e75-8a3d-4880-b2f9-a76e7871234e/small/paog-new-logo-jpg.jpg
https://ml.globenewswire.com/media/508f5e75-8a3d-4880-b2f9-a76e7871234e/small/paog-new-logo-jpg.jpg
comtex tracking
COMTEX_401366350/2010/2022-01-28T16:57:52
Oh, the wagon. Classic. lol.
10:15a ET 1/25/2022 - Globe Newswire
PAOG Cites Research On Hemp Compounds Effectiveness Treating Covid To Advance Pharmaceutical Development
Mentioned: PAOG
PAO Group, Inc. (OTC Pink: PAOG) today cited recently published information on research indicating CBDA and CBGA, compounds found in hemp, "block a critical step in the process the [Covid] virus uses to infect people" (source).
"The two compounds were identified during a chemical screening by researchers at the Linus Pauling Institute at Oregon State University. The compounds bind to spike proteins found on the virus and blocked the spike protein from binding to sites in a human host, thereby preventing a step the pathogen uses to infect people" (source).
PAOG owns intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960).
PAOG is developing both pharmaceutical and nutraceutical treatments for humans based on this intellectual property.
PAOG's CBD formulation, derived from a patented cannabis extraction process, is years in the making for the treatment of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. PAOG is developing the CBD formulation with the intent of delivering an approved pharmaceutical treatment under the brand name RespRx.
PAOG considers the recent hemp compound research regarding Covid as potential validation of the respiratory benefits of RespRx, and also potentially beneficial in advancing PAOG's ongoing research with RespRx.
PAOG currently markets its own independent line of CBD nutraceutical products under its "RX" label available for sale on North American Cannabis Inc.'s (OTC Pink: USMJ) ecommerce site www.usmj.com.
PAOG has recently announced the development of a new line of CBD nutraceutical products for Puration, Inc. (OTC Pink: PURA) now underway.
PAOG plans to publish a 2022 strategic update this Friday, January 28, 2022.
For more information on Puration, visit http://www.purationinc.com
Learn more about PAOG at www.paogroupinc.com.
Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.
For More Information Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Jim DiPrima
888-272-6472
info@pao.group
https://ml.globenewswire.com/media/508f5e75-8a3d-4880-b2f9-a76e7871234e/small/paog-new-logo-jpg.jpg
https://ml.globenewswire.com/media/508f5e75-8a3d-4880-b2f9-a76e7871234e/small/paog-new-logo-jpg.jpg
comtex tracking
COMTEX_401178361/2010/2022-01-25T10:15:27
Let's not forget about his Little Red Wagon!
i seen the movie it was called karl screw all stockholders!!!!!!!!
Bet you didnt know he has a little movie...
of the antique car driving off with our money.
To hear him tell it, it is a movie about the "launch" of his company "High End Products" at the High Times Cup in Detroit. To PAOG shareholders it's a bitter reminder of how he used their company, it's products, reputation and resources to launch his pos company... JMHO
One year ago, we launched HIGH END Products at the HIGH TIMES Cannabis Cup 🏆 Detroit...#hightimes #cannabiscup #gethighend pic.twitter.com/l0CdTl7MEL
— HIGH END Products® (@gethighend) August 18, 2020
No hope, just another dump day!
Exactly reason sell December. This company went through a lot up and downs. Mainly just from the Board members that killed this stock a few years ago. But hold and recovery with management. But still oddly slow on real information. Oddly slow on all fronts. Made baby profit.
What happened to all of those billions that we were going to make from all of the new products that they released at the end of last year.?
Domino's CEO doesn't do CBD/thc infused bacon double cheeseburger floats on pepproni. There's no hope for this pos paog
Shake Shack buyiut ? Cbd thc infused patty melts maybe the wayout of of the future pandemics
The CEO's other SCAM - RBII was shut down by the SEC a long time ago.. I can't believe this SCAM is still trading...
But yet the share price is….bhawhahahahahahahaha….just another bs pr …..see Rbii
Followers
|
1012
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
158817
|
Created
|
10/20/05
|
Type
|
Free
|
Moderators BasedOnFeels |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |